Analyst opinion excerpts from Agis, Cannacord, Roth, and Cantor as follows: Cantor – One year price target = $11 SGYP: 3Q Recap – 2014 Catalysts Approaching SGYP reported uneventful 3Q13 results. We expect investor attention in SGYP shares to increase…
Explaining in brief Solta’s Current Situation in The Tender Offer
http://www.mofo.jp/topics/legal-updates/legal-updates/93.html The above explains in quite a lot of detail how tender offers work. Since the sltm deal is a “friendly” tender offer, the minimum time to close such a deal is normally 30 calendar days. The Williams act provides…
Video: Commentary and Charts 12/25/13
Video: Commentary and Charts 12/25/13. $SRPT, $PGNX, $SGYP $INWK covered along with some market commentary for the rest of this week, enjoy! Scott
Solta Medical Agrees To Be Acquired By Valeant, But Another Bid Might Emerge
On Monday, December 16th, Valeant (VRX) submitted what for the time being, is the winning bid to acquire Solta Medical Devices (SLTM). For some time now, we have been predicting that Solta would be acquired before the end of this…
Video: Commentary and Charts For 12/22/13
Video: Commentary and Charts For 12/22/13. $XOMA $PGNX, $SGYP, $SRPT, $ATRS $INWK covered. Enjoy! Scott
Podcast Of Dec. 21 Webinar Here – Understanding Mangement Guidance
Saturday’s Webinar – Understanding Mangement Guidance. Start time – 6 pm eastern time. Covered: 1. How to read guidance by management and how it effects stock prices. 2. Recognizing the difference between over,under, and equal guidance. 3. Developing a trade…
Updated: Following Smart Money: The Baker Brothers LLC Investments In 2013 And Beyond
Perhaps the most important buying indicator for a developmental pharma is who is buying the stock. At stockmatusow, we have had the most success with our trades and investments when we “follow the smart money.” When push comes to shove,…
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
Pre Market Commentary 12/17/13
Pre Market Commentary 12/17/13. $SLTM $CNMD $INWK. Solta situation explained, and why I am not selling now. Conmed activism – VOCE target, likely acquisition next year on that one for over $50, I am considering options there. Scott
Video: Market Commentary and Charts 12/16/13
Video: Market Commentary and Charts 12/16/13. $SLTM $IBB $ATRS $INWK $SRPT $SSH $QQQ $SPY covered. Fed Taper discussion and more, give it a listen and GL trading this week! Scott
